Key facts
- Notable investors include EnjoyVenture, OCCIDENT (), Peppermint Venture Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for G-Metrics
- ·The full record, as it builds
Funding rounds
No funding rounds for G-Metrics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About G-Metrics
Developer of glaucoma monitoring and digital health systems designed to support continuous intraocular pressure tracking and personalized therapy guidance for glaucoma care. The company's platform uses smart connected biosensors, continual monitoring of intraocular pressure, cloud-based data analytics, and real-time reporting to detect disease progression and inform clinical decisions, enabling patients and healthcare providers to manage glaucoma better, reduce the risk of vision loss, and improve long-term eye health outcomes within the medical devices and ophthalmic digital health market.
- Sector
- Healthcare
- HQ
- Hannover, Germany
- Founded
- 2010
- Employees
- 7
- Website
- g-metrics.health/
- Ownership
- Privately Held (backing)
G-Metrics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in G-Metrics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on G-Metrics in its N-PORT filings yet. We sweep new filings monthly.